Advertisement

Topics

CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial

09:00 EDT 10 Apr 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis" or the "Company"), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for acute a...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...